Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges

被引：8
|
作者：
Ceresoli, Giovanni Luca [1 ]
Bonomi, Maria [1 ]
Sauta, Maria Grazia [1 ]
机构：
[1] Clin Humanitas Gavazzeni, Thorac & GU Oncol Unit, Dept Med Oncol, I-24125 Bergamo, Italy
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2016年 / 16卷 / 07期
关键词：
Malignant pleural mesothelioma; immunotherapy; immune-checkpoint inhibitors; SINGLE-ARM; OPEN-LABEL; TREMELIMUMAB; CISPLATIN; BLOCKADE; PHASE-2; CANCER; SAFETY;
D O I：
10.1080/14737140.2016.1191951
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：673 / 675
页数：3
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in malignant pleural mesothelioma
    Ceresoli, Giovanni Luca
    Mantovani, Alberto
    LANCET ONCOLOGY, 2017, 18 (05): : 559 - 561
  • [2] Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
    Metro, Giulio
    Signorelli, Diego
    Pizzutilo, Elio G.
    Giannetta, Laura
    Cerea, Giulio
    Garaffa, Miriam
    Friedlaender, Alex
    Addeo, Alfredo
    Mandarano, Martina
    Bellezza, Guido
    Roila, Fausto
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (09) : 2972 - 2980
  • [3] Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma
    Farina, Antonio
    Escalere, Manon
    Dion, Matthias
    Moussy, Martin
    Pegat, Antoine
    Villagran-Garcia, Macarena
    Devic, Perrine
    Lamiral, Anaide
    Seyve, Antoine
    Aure, Karine
    Wang, Adrien
    Gorza, Lucas
    Streichenberger, Nathalie
    Maisonobe, Thierry
    Honnorat, Jerome
    Birzu, Cristina
    Psimaras, Dimitri
    Weisenburger-Lile, David
    Joubert, Bastien
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [4] Proton Beam Therapy and Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma
    McCusker, Michael G.
    Scilla, Katherine A.
    Simone, Charles B., II
    Sachdeva, Ashutosh
    Miller, Kenneth D.
    Burke, Allen P.
    Rolfo, Christian
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (09) : E185 - E187
  • [5] Multiomics analysis of malignant pleural mesothelioma and the effect of immune checkpoint inhibitors
    Tateishi, A. T.
    Yoshida, T.
    Shiraish, K.
    Torasawa, M.
    Igawa, Y.
    Masuda, K.
    Shinno, Y.
    Okuma, Y.
    Goto, Y.
    Horinouchi, H.
    Yamamoto, N.
    Kohno, T.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S1117 - S1117
  • [6] The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
    Borgeaud, Maxime
    Kim, Floryane
    Friedlaender, Alex
    Lococo, Filippo
    Addeo, Alfredo
    Minervini, Fabrizio
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [7] True Benefits of Immune Checkpoint Inhibitors in the Treatment of Malignant Pleural Mesothelioma in Japan
    Kuribayashi, Kozo
    Hirano, Jun
    ANTICANCER RESEARCH, 2024, 44 (10) : 4135 - 4145
  • [8] Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma
    Wanyuan Cui
    Sanjay Popat
    Drugs, 2021, 81 : 971 - 984
  • [9] Immune checkpoint inhibitor therapy for malignant pleural mesothelioma
    Nowak, Anna K.
    Chin, Wee Loong
    Keam, Synat
    Cook, Alistair
    LUNG CANCER, 2021, 162 : 162 - 168
  • [10] Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma
    Cui, Wanyuan
    Popat, Sanjay
    DRUGS, 2021, 81 (09) : 971 - 984
12345